936501-00-7 (3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione,3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1h-quinazoline-2,4-dione)

CAS号:
936501-00-7
中文名称:
3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione
英文名称:
3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1h-quinazoline-2,4-dione
分子式:
C15H13FN4O2
分子量:
300.287726163864

3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione(936501-00-7)名称与标识符

名称

中文别名:
3-(4-氨基苯基)-6-氟-7-(甲基氨基)喹唑啉-2,4(1H,3H)-二酮;
英文别名:
3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione;3-(4-AMINOPHENYL)-6-FLUORO-7-(METHYLAMINO)QUINAZOLINE-2,4(1H,3H)-DIONE;SureCN195280;CTK5H2757;AG-H-82650;3-(4-Aminophenyl)-6-fluoro-7-(methylamino)-2,4(1H,3H)-quinazolinedione (ACI);3-(4-Aminophenyl)-6-fluoro-7-(methylamino)-1,2,3,4-tetrahydroquinazoline-2,4-dione;CSUGIYPBKRLZAN-UHFFFAOYSA-N;3-(4-aminophenyl)-6-fluoro-7-(methylamino)quinazoline-2,4(1h, 3h)-dione;936501-00-7;DTXSID20647279;BCP24512;CS-0432807;DB-228342;AS-81946;AKOS015995468;SCHEMBL195280;MFCD13250189;

标识符

MDL:
MFCD13250189
InChIKey:
CSUGIYPBKRLZAN-UHFFFAOYSA-N
Inchi:
1S/C15H13FN4O2/c1-18-13-7-12-10(6-11(13)16)14(21)20(15(22)19-12)9-4-2-8(17)3-5-9/h2-7,18H,17H2,1H3,(H,19,22)
SMILES:
O=C1N(C2C=CC(N)=CC=2)C(=O)C2C(=CC(=C(C=2)F)NC)N1

3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione(936501-00-7)物化性质

实验特性

  • LogP : 2.09620
  • PSA : 92.91000

计算特性

  • 精确分子量 : 300.10200
  • 氢键供体数量 : 3
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 2
  • 同位素质量 : 300.10225383g/mol
  • 重原子数量 : 22
  • 复杂度 : 453
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.6
  • 拓扑分子极性表面积 : 87.5Ų

3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione(936501-00-7)推荐厂家 更多厂家(10)

3-(4-aminophenyl)-6-fluoro-7-(methylamino)-1H-quinazoline-2,4-dione(936501-00-7)合成路线

合成路线:1 步
反应条件:
参考文献:
Preparation of N-[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-N'-(5-chlorothiophen-2-ylsulfonyl)urea salts, forms and methods related thereto
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of 5-chloro-N-[[[4-[6-fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-2-thiophenesulfonamide and its salts and polymorph forms as platelet ADP receptor inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas as ADP receptor inhibitors for treatment of cardiovascular diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Process for preparation of quinazolinylphenylthienylsulfonylureas.
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of elinogrel
Yuan, Qiu-hui; Tang, Qi-dong; Chai, Yu-zhu; Zhu, Wu-fu; Guo, Qiu-ting; et al, Zhongguo Yaowu Huaxue Zazhi, 2012, 22(4), 286-289
合成路线:1 步
反应条件:
参考文献:
Combination antithrombotic therapy with a sulfonylurea compound acting as a platelet ADP receptor inhibitor
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Intravenous and oral dosing of a direct-acting and reversible P2Y12 inhibitor
, World Intellectual Property Organization, , ,